Hyperlipidemia in experimental disseminated intravascular coagulation.
D000614:Aminocaproates; D000704:Analysis of Variance; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002784:Cholesterol / Q000097:blood; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000139:chemically induced / Q000150:complications*; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006949:Hyperlipidemias / Q000209:etiology*; D007673:Kidney Cortex Necrosis / Q000139:chemically induced; D007678:Kidney Glomerulus / Q000187:drug effects; D007773:Lactates / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000473:pathology; D008297:Male; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D013917:Thrombin / Q000494:pharmacology; D013927:Thrombosis / Q000139:chemically induced; D014280:Triglycerides / Q000097:blood
D000614:Aminocaproates; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D010643:Phenoxybenzamine; D000804:Angiotensin II; D002784:Cholesterol; D011433:Propranolol; D013917:Thrombin; D004837:Epinephrine